4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine, 95%, 1g

(5E)-5-(5-chloro-2-hydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 1g

METHYL 5,5-DIFLUOROPIPERIDINE-3-CARBOXYLATE HCL, 95.0%, 1g

(R)-2-Amino-2-(cyclohexa-1,4-dien-1-yl)acetic acid, 97.0%, 500g

6-amino-2-methyl-3,4-dihydropyrimidin-4-one dihydrate, 95%, 1g

4-(4-((4-(Benzo[d]thiazol-2-yl(cyano)methyl)pyrimidin-1-ium-2-yloxy)methyl)benzyl)morpholin-4-ium (2,2,2-trifluoroacetate), 98%, 500mg

4-Thiocarbamoyl-benzoic acid methyl ester, 95.0%, 250mg

2-(3-Bromophenyl)propan-2-amine hydrochloride, 95.0%, 10g

(E)-4,4,5,5-Tetramethyl-2-(pent-1-en-1-yl)-1,3,2-dioxaborolane, 98.0%, 100mg

Cubetas de un solo uso ROTILABO® resistentes a disolventes, Macro, 100 pieza(s)

(4-Bromo-1H-indol-6-yl)methanol, 5g

tert-Butyl 2-hydroxy-2-methylpropylcarbamate, 95.0%, 250mg

4-Bromo-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 96%, 10g